<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id><journal-title>BMC Genomics</journal-title><issn pub-type="epub">1471-2164</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2164-10-241</article-id><article-id pub-id-type="pmid">19463170</article-id><article-id pub-id-type="doi">10.1186/1471-2164-10-241</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>A transcript profiling approach reveals the zinc finger transcription factor ZNF191 is a pleiotropic factor</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Li</surname><given-names>Jianzhong</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>lijianzhong1234@yahoo.com</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Chen</surname><given-names>Xia</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>chenxia1978@yahoo.com</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Gong</surname><given-names>Xuelian</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>witous2002@hotmail.com</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Liu</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>liuchanger1984@163.com</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Feng</surname><given-names>Hao</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>fenghsmmu2001@yahoo.com.cn</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Qiu</surname><given-names>Lei</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>quilei72@hotmail.com</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Hu</surname><given-names>Zhenlin</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>zhenlinhu@hotmail.com</email></contrib><contrib id="A8" corresp="yes" contrib-type="author"><name><surname>Zhang</surname><given-names>Junping</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jpzhang08@hotmail.com</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Biochemical Pharmacy, Second Military Medical University, Shanghai, PR China</aff><aff id="I2"><label>2</label>Shanghai Research Center of Biotechnology, Chinese Academy of Sciences, Shanghai, PR China</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>22</day><month>5</month><year>2009</year></pub-date><volume>10</volume><fpage>241</fpage><lpage>241</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2164/10/241"/><history><date date-type="received"><day>27</day><month>9</month><year>2008</year></date><date date-type="accepted"><day>22</day><month>5</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Li et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Li et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Li Jianzhong lijianzhong1234@yahoo.com </dc:author><dc:title> A transcript profiling approach reveals the zinc finger transcription factor ZNF191 is a pleiotropic factor </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>BMC Genomics 10(1): 241-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2164(2009)10:1&#x0003c;241&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2164</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>The human zinc finger protein 191 (ZNF191) is a member of the SCAN domain family of Kr&#x000fc;ppel-like zinc finger transcription factors. ZNF191 shows 94% identity to its mouse homologue zinc finger protein 191(Zfp191), which is the most highly conserved among the human-mouse SCAN family member orthologues pairs. Zfp191 is widely expressed during early embryogenesis and in adult organs. Moreover, Zfp191<sup>-/- </sup>embryos have been shown to be severely retarded in development and die approximately at embryonic day E7.5. ZNF191 can specifically interact with the widespread TCAT motif which constitutes the HUMTH01 microsatellite in the tyrosine hydroxylase (TH) gene. Allelic variations of HUMTH01 have been stated to have a quantitative silencing effect on TH gene expression and to correlate with quantitative and qualitative changes in the binding by ZNF191. In addition, ZNF191 displays a suppressive effect on the transcription; however, little downstream targets have identified.</p></sec><sec><title>Results</title><p>We searched for ZNF191 target genes by using a transient overexpression and knockdown strategy in the human embryo kidney (HEK293) cells. Microarray analyses identified 6094 genes modulated by overexpression of <italic>ZN</italic>F191 and 3332 genes regulated by knockdown of ZNF191, using a threshold of 1.2-fold. Several interested candidate genes, validated by real time RT-PCR, were correlated well with the array data. Interestingly, 1456 genes were identified in both transient overexpression and transient knockdown strategies. The GenMAPP and MappFinder software packages were further used for pathway analysis of these significantly altered genes. Several gene pathways were found to be involved in processes of the regulation of kinase activity, transcription, angiogenesis, brain development and response to DNA damage.</p></sec><sec><title>Conclusion</title><p>Our analysis reveals for the first time that ZNF191 is a pleiotropic factor that has a role in hematopoiesis, brain development and cancers.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>The regulation of gene expression in response to intrinsic and extrinsic cues is a fundamental cellular process in the growth and development of organisms. Critical to the control of gene expression are transcription factors that bind to specific DNA sequences and subsequently modulate gene transcription [<xref ref-type="bibr" rid="B1">1</xref>]. A significant number of transcription factors use a conserved zinc finger domain to bind their target DNAs. Zinc finger factors participate in a variety of cellular activities, such as development and differentiation, and play a role in human disease. In fact, the human genome encompasses approximately 600 to700 genes that contain a particular C<sub>2</sub>H<sub>2</sub>-type of zinc finger, which employs two cysteine and two histidine amino acid residues to coordinate the single zinc atom in the finger-like structure [<xref ref-type="bibr" rid="B2">2</xref>-<xref ref-type="bibr" rid="B4">4</xref>]. In the C<sub>2</sub>H<sub>2</sub>-type of zinc finger proteins, there is a highly conserved consensus sequence TGEKP(F/Y)X (X representing any amino acid) between adjacent zinc finger motifs. The zinc finger proteins containing this specific structure are termed Kr&#x000fc;ppel-like zinc finger proteins because the structure was first found in <italic>Drosophila </italic>Kr&#x000fc;ppel protein [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. Many Kr&#x000fc;ppel-like factors exhibit diverse regulatory functions in cell growth, proliferation, differentiation, and embryogenesis [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B10">10</xref>]. The SCAN (<underline>S</underline>RE-ZBP, <underline>C</underline>tfin 51, <underline>A</underline>W-1, and <underline>N</underline>umber 18) [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>], which is also known as the leucine rich region (LeR) [<xref ref-type="bibr" rid="B12">12</xref>], KRAB (<underline>Kr</underline>&#x000fc;ppel-<underline>a</underline>ssociated <underline>b</underline>ox) [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B13">13</xref>], and POZ (<underline>po</underline>xvirus and <underline>z</underline>inc finger) [<xref ref-type="bibr" rid="B14">14</xref>] domains are highly conserved modules found in the N-terminus of C<sub>2</sub>H<sub>2 </sub>zinc finger transcription factors that have been demonstrated to mediate specific protein-protein interactions [<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. The SCAN domain is a conserved motif that appears to control the association of SCAN-containing proteins into non-covalent complexes, and may be the primary mechanism underlying partner choice in the dimerization of these transcription factors [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B19">19</xref>-<xref ref-type="bibr" rid="B22">22</xref>]. The genes encoding SCAN domains are clustered, often in tandem arrays, in both the human and mouse genomes and are capable of generating isoforms that may affect the function of family members. Although the function of most of the family members is not known, some of the SCAN domain family members play roles in cell survival and differentiation or development [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B23">23</xref>-<xref ref-type="bibr" rid="B25">25</xref>]. Like the KRAB motif, the SCAN domain-containing C<sub>2</sub>H<sub>2 </sub>zinc finger proteins are unique to the vertebrate lineage [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>].</p><p>Human zinc finger protein 191 (ZNF191, also known as ZNF24 and KOX(17) [<xref ref-type="bibr" rid="B10">10</xref>]) is a member of the SCAN domain family of Kr&#x000fc;ppel-like zinc finger transcription factors [<xref ref-type="bibr" rid="B15">15</xref>]. This gene is initially named as <italic>RSG-A </italic>(for retinoic acid suppressed gene-A) because its mRNA can be amplified by homologous RT-PCR only in retinoic acid-untreated but not in retinoic acid-treated acute promyelocytic leukemia NB4 cells[<xref ref-type="bibr" rid="B26">26</xref>]. ZNF191 shows 94% identity to its mouse homologue zinc finger protein 191(Zfp191, also called ZF-12), which is the most highly conserved among the human-mouse SCAN family member orthologues pairs[<xref ref-type="bibr" rid="B16">16</xref>]. Tissue mRNA analysis showed that <italic>ZNF191 </italic>gene was ubiquitously expressed [<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. The mouse <italic>Zfp191 </italic>has been previously isolated from chondrocytic and mesenchymal precursor cell lines using a subtractive hybridization screening. <italic>Zfp191 </italic>mRNA is expressed during embryonic development and in different organs in adult, including rib cartilage, suggesting that <italic>Zfp191 </italic>may have a role in cartilage differentiation and in basic cellular processes[<xref ref-type="bibr" rid="B28">28</xref>].</p><p>A study demonstrated that ZNF191 <bold>c</bold>an specifically bind to the TCAT repeats (HUMTH01) in the first intron of the human tyrosine hydroxylase (<italic>TH</italic>) gene, which encodes the rate-limiting enzyme in the synthesis of catecholamines [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. Allelic variations of HUMTH01 have a quantitative silencing effect on <italic>TH </italic>gene expression in vitro, and correlate with quantitative and qualitative changes in the binding by ZNF191 [<xref ref-type="bibr" rid="B27">27</xref>]. <italic>ZNF191 </italic>mRNA levels was present at high levels in catecholaminergic tissues including the substantia nigra, the hypothalamus and the olfactory bulb. In the rat embryo, the mRNA was present at high levels in total embryonic head, which may reflect a role in brain development [<xref ref-type="bibr" rid="B27">27</xref>]; however, the molecular mechanisms remain unknown.</p><p>The <italic>ZNF191 </italic>gene is located on chromosome 18q12.1[<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B26">26</xref>], a region frequently deleted in colorectal carcinomas, suggesting a possible role in the negative regulation of tumor growth[<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>]. ZNF191 contains four continuous typical C<sub>2</sub>H<sub>2 </sub>zinc fingers in its C-terminus, and one SCAN domain in its N-terminus [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B26">26</xref>]. Biochemical binding study shows the SCAN domain of ZNF191 as a selective oligomerization domain[<xref ref-type="bibr" rid="B20">20</xref>]. The SCAN domain of ZNF191 displays a suppressive effect on the transcription in CHO and NIH3T3 cells[<xref ref-type="bibr" rid="B26">26</xref>]; however, little else is known regarding its role in gene expression.</p><p>In the present study, we transiently overexpressed and silenced <italic>ZNF191 </italic>gene in the human embryo kidney (HEK293) cells and then applied microarray assay to identify possible <italic>ZNF191 </italic>target genes. Expression of interested candidate genes was also examined by real time RT-PCR, and these data correlated well with the array data. In general, our data reveal that ZNF191 modulates the expression of a large number of genes that are implicated in regulation of kinase activity, regulation of transcription, angiogenesis, brain development and response to DNA damage. Our analysis reveals for the first time that ZNF191 is a pleiotropic factor that has a role in hematopoiesis, brain development, tumor growth.</p></sec><sec><title>Results</title><sec><title>Data analysis: general features</title><p>To identify ZNF191 target genes, a combined approach of transient overexpression and transient knockdown (KD) are used to identify genes modified by the ZNF191 transcription factor with 44 K Whole-Genome 60-mer oligonucleotide microarrays, using a cellular model (HEK293). Plasmids overexpressing <italic>ZNF191 </italic>cDNA (pcDNA3-ZNF191) or control empty pcDNA3 vectors were transiently transfected into HEK293 cells for 24 hours. As expected, introduction of pcDNA3-ZNF191 in HEK293 cells resulted in higher expression of <italic>ZNF191 </italic>mRNA than in cells transfected with control empty plasmid or untreated cells (Figure <xref ref-type="fig" rid="F1">1A</xref>). Real-time PCR results showed that the <italic>ZNF191 </italic>expression level was increased &#x0003e; 30 times in cells transfected with pcDNA3-ZNF191 compared with control cells (Figure <xref ref-type="fig" rid="F1">1B</xref>). For the reduction of <italic>ZNF191 </italic>expression, three hairpin siRNA expression vectors against <italic>ZNF191 </italic>were generated [<xref ref-type="bibr" rid="B32">32</xref>] and the knock-down of ZNF191 was assessed 48 hours after transfection of the HEK293 cells. Figure <xref ref-type="fig" rid="F2">2</xref> showed that the three siRNA expression vectors were found to efficiently eliminate the target mRNA. The reduction of ZNF191 mRNA levels in transfected cells appears to be approximately 60% at the best compared to the control level. Due to no greater inhibition of <italic>ZNF191 </italic>mRNA at longer times than 48 hours, transfection of the HEK293 cells with the most efficient vector for 48 h was used in subsequent experiments.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>RT-PCR analysis of the <italic>ZNF191 </italic>gene expression in HEK293 cells transfected with pcDNA3-ZNF191 or pcDNA3 and untreated cells</bold>. (A) Semiquantitative RT-PCR analysis of the <italic>ZNF191 </italic>gene expression in the transfected cells and untreated cells. Total cellular RNA was isolated from pcDNA3-ZNF191 or pcDNA3 transfectants and untreated cells, and, after reverse transcription, PCR was performed with ZNF191- and GAPDH- specific primers. The up-regulation of the 481-bp ZNF191-specific band was detected in cells transfected with pcDNA3-ZNF191 plasmid. (B) Quantitative RT-PCR analysis of the relative ZNF191/GAPDH expression in the transfected cells and untreated cells.</p></caption><graphic xlink:href="1471-2164-10-241-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>RT-PCR analysis of the <italic>ZNF191 </italic>gene expression in HEK293 cells transfected with <italic>ZNF191 </italic>siRNA expression vectors or empty plasmid</bold>. (A) Semiquantitative RT-PCR analysis of the <italic>ZNF191 </italic>gene expression in the transfected cells. RT-PCR and gel electrophoresis of amplified products. The sizes of the amplified products are 481 bp (ZNF191) and 381 bp (GAPDH). Lane 1, the control cells (transfected with empty vector). Lane 2, lane 3, or lane 4, HEK293 cells transfected with pSZNF191-1, -2, or -3 (ZNF191 siRNA expression vectors), respectively. Lane 5, DNA size marker. (B) Quantitative RT-PCR analysis of the relative <italic>ZNF191</italic>/<italic>GAPDH </italic>expression in the transfected cells. Lane 1, the control cells (transfected with empty vector). Lane 2, lane 3, or lane 4, HEK293 cells transfected with pSZNF191-1, -2, or -3, respectively.</p></caption><graphic xlink:href="1471-2164-10-241-2"/></fig><p>RNA samples were prepared from the transient overexpression and transient knockdown cells as well as control cells. Probe labelling, hybridization, and scanning were done by Shanghai Biochip Co., Ltd (China). The complete list of genes with differential expression can be found at the website <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE14273"/>. Microarray showed that 3273 genes were up-regulated more than 1.2-fold, while 3631 were down-regulated by the overexpression of the <italic>ZNF191 </italic>gene (see Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>), while 2111 were up-regulated by the KD and 1221 were down-regulated, using the same threshold (see Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>). Interestingly, 1456 genes were identified in both situations, and 1344 (92%) behaved consistently between the two experiments (i.e. induced by the overexpression and repressed by the KD, or the other way around) (see Additional file <xref ref-type="supplementary-material" rid="S3">3</xref>). These identified genes were subsequently used in pathway analysis with MappFinder.</p><p>Using a threshold of 2 for data analysis, 592 genes were found to be regulated by the overexpression with 143 genes up-regulated and 449 down-regulated (see Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>, highlighted data) while 172 genes were regulated by the KD with 83 genes up-regulated and 89 down-regulated (see Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>, highlighted data). The overlap was found between transient overexpression and transient knockdown with 69 shared genes(see Additional file <xref ref-type="supplementary-material" rid="S3">3</xref>, highlighted data). Thus, ZNF191 appears to modulate multiple transcriptional events, acting both as an activator and a repressor.</p></sec><sec><title>Pathway analysis of the ZNF191 transient overexpression and knockdown signature</title><p>To further evaluate our microarray data, GenMAPP and MAPPFinder software <ext-link ext-link-type="uri" xlink:href="http://www.genmapp.org"/> were used to organize gene expression data into MAPPs (microarray pathway profiles) that represent specific biological pathways and functionally grouped genes, based on the GO system. Three main classes of branches in the GO tree are biological processes, molecular functions and cellular components [<xref ref-type="bibr" rid="B33">33</xref>].</p><p>We focused on microarray gene expression data of 1456 genes identified in both transient overexpression and transient knockdown treatment. Using gene-association files from the GO Consortium, MAPPFinder assigns the thousands of genes in the dataset to numerous GO terms. Our analysis was limited to the GO terms that comprise more than eight genes in a class. Several significant (i.e., z score &#x0003e; 2) functional MAPPs were revealed with MAPPFinder and were presented in Table <xref ref-type="table" rid="T1">1</xref>. Gene pathways that are involved in the <italic>regulation of kinase activity and angiogenesis </italic>were significantly up-regulated. In contrast, processes associated with <italic>response to DNA damage stimulus and brain development </italic>were down-regulated. Many up-regulated processes are localized to <italic>cellular component </italic>(endoplasmic reticulum) while down-regulated processes belong mainly to the <italic>cellular components </italic>(ribosome, extracellular matrix and cytoplasmic membrane-bound vesicle). Figure <xref ref-type="fig" rid="F3">3</xref>, <xref ref-type="fig" rid="F4">4</xref>, <xref ref-type="fig" rid="F5">5</xref> and <xref ref-type="fig" rid="F6">6</xref> and Table <xref ref-type="table" rid="T2">2</xref> showed the <italic>ZNF191 </italic>overexpression and <italic>ZNF191 </italic>knockdown differentially expressed genes involved in these signaling pathways.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Identification of significantly changed molecular pathways by mappfinder analysis of the significantly altered genes in both transient overexpression and transient knockdown of the <italic>ZNF191 </italic>gene.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>GOID</bold></td><td align="left"><bold>Pathway Name/GO Term</bold></td><td align="left"><bold>NO. genes</bold></td><td align="left"><bold>% Changed</bold></td><td align="left"><bold>Z-score</bold></td></tr></thead><tbody><tr><td align="left" colspan="5"><bold>Up-regulated in overexpression and down-regulated in KD</bold></td></tr><tr><td align="left">&#x02003;43549</td><td align="left">regulation of kinase activity</td><td align="left">12</td><td align="left">60</td><td align="left">2.73</td></tr><tr><td align="left">&#x02003;45859</td><td align="left">regulation of protein kinase activity</td><td align="left">12</td><td align="left">60</td><td align="left">2.73</td></tr><tr><td align="left">&#x02003;165</td><td align="left">MAPKKK cascade</td><td align="left">8</td><td align="left">66.7</td><td align="left">2.60</td></tr><tr><td align="left">&#x02003;51338</td><td align="left">regulation of transferase activity</td><td align="left">12</td><td align="left">57.1</td><td align="left">2.51</td></tr><tr><td align="left">&#x02003;65008</td><td align="left">regulation of biological quality</td><td align="left">15</td><td align="left">53.6</td><td align="left">2.51</td></tr><tr><td align="left">&#x02003;22402</td><td align="left">cell cycle process</td><td align="left">21</td><td align="left">47.7</td><td align="left">2.32</td></tr><tr><td align="left">&#x02003;1525</td><td align="left">angiogenesis</td><td align="left">8</td><td align="left">61.5</td><td align="left">2.31</td></tr><tr><td align="left">&#x02003;6952</td><td align="left">defense response</td><td align="left">13</td><td align="left">52</td><td align="left">2.19</td></tr><tr><td align="left">&#x02003;6508</td><td align="left">proteolysis</td><td align="left">12</td><td align="left">52.2</td><td align="left">2.12</td></tr><tr><td align="left">&#x02003;48514</td><td align="left">blood vessel morphogenesis</td><td align="left">8</td><td align="left">57.1</td><td align="left">2.04</td></tr><tr><td align="left">&#x02003;7264</td><td align="left">small GTPase mediated signal transduction</td><td align="left">10</td><td align="left">52.6</td><td align="left">1.96</td></tr><tr><td align="left">&#x02003;5515</td><td align="left">protein binding</td><td align="left">108</td><td align="left">36.9</td><td align="left">2.38</td></tr><tr><td align="left">&#x02003;5525</td><td align="left">GTP binding</td><td align="left">9</td><td align="left">60</td><td align="left">2.36</td></tr><tr><td align="left">&#x02003;30246</td><td align="left">carbohydrate binding</td><td align="left">10</td><td align="left">55.6</td><td align="left">2.18</td></tr><tr><td align="left">&#x02003;19001</td><td align="left">guanyl nucleotide binding</td><td align="left">9</td><td align="left">56.3</td><td align="left">2.11</td></tr><tr><td align="left">&#x02003;5783</td><td align="left">endoplasmic reticulum</td><td align="left">15</td><td align="left">48.4</td><td align="left">2.01</td></tr><tr><td align="left" colspan="5"><bold>Down-regulated in overexpression and up-regulated in KD</bold></td></tr><tr><td align="left">&#x02003;6066</td><td align="left">alcohol metabolic process</td><td align="left">14</td><td align="left">100</td><td align="left">2.56</td></tr><tr><td align="left">&#x02003;45449</td><td align="left">regulation of transcription</td><td align="left">95</td><td align="left">77.9</td><td align="left">2.45</td></tr><tr><td align="left">&#x02003;9719</td><td align="left">response to endogenous stimulus</td><td align="left">17</td><td align="left">94.4</td><td align="left">2.40</td></tr><tr><td align="left">&#x02003;6974</td><td align="left">response to DNA damage stimulus</td><td align="left">17</td><td align="left">94.4</td><td align="left">2.40</td></tr><tr><td align="left">&#x02003;19219</td><td align="left">regulation of nucleobase\, nucleoside\, nucleotide and nucleic acid metabolic process</td><td align="left">95</td><td align="left">77.2</td><td align="left">2.30</td></tr><tr><td align="left">&#x02003;7420</td><td align="left">brain development</td><td align="left">11</td><td align="left">100</td><td align="left">2.27</td></tr><tr><td align="left">&#x02003;6355</td><td align="left">regulation of transcription\, DNA-dependent</td><td align="left">89</td><td align="left">77.4</td><td align="left">2.25</td></tr><tr><td align="left">&#x02003;6350</td><td align="left">transcription</td><td align="left">96</td><td align="left">76.8</td><td align="left">2.21</td></tr><tr><td align="left">&#x02003;3735</td><td align="left">structural constituent of ribosome</td><td align="left">15</td><td align="left">100</td><td align="left">2.65</td></tr><tr><td align="left">&#x02003;46872</td><td align="left">metal ion binding</td><td align="left">153</td><td align="left">75.7</td><td align="left">2.63</td></tr><tr><td align="left">&#x02003;43167</td><td align="left">ion binding</td><td align="left">154</td><td align="left">75.1</td><td align="left">2.43</td></tr><tr><td align="left">&#x02003;43169</td><td align="left">cation binding</td><td align="left">140</td><td align="left">75.3</td><td align="left">2.32</td></tr><tr><td align="left">&#x02003;3676</td><td align="left">nucleic acid binding</td><td align="left">129</td><td align="left">75.4</td><td align="left">2.25</td></tr><tr><td align="left">&#x02003;46914</td><td align="left">transition metal ion binding</td><td align="left">103</td><td align="left">76.3</td><td align="left">2.17</td></tr><tr><td align="left">&#x02003;35091</td><td align="left">phosphoinositide binding</td><td align="left">10</td><td align="left">100</td><td align="left">2.16</td></tr><tr><td align="left">&#x02003;8270</td><td align="left">zinc ion binding</td><td align="left">94</td><td align="left">76.4</td><td align="left">2.09</td></tr><tr><td align="left">&#x02003;4930</td><td align="left">G-protein coupled receptor activity</td><td align="left">9</td><td align="left">100</td><td align="left">2.05</td></tr><tr><td align="left">&#x02003;16023</td><td align="left">cytoplasmic membrane-bound vesicle</td><td align="left">11</td><td align="left">100</td><td align="left">2.27</td></tr><tr><td align="left">&#x02003;5830</td><td align="left">cytosolic ribosome (sensu Eukaryota)</td><td align="left">11</td><td align="left">100</td><td align="left">2.27</td></tr><tr><td align="left">&#x02003;5578</td><td align="left">proteinaceous extracellular matrix</td><td align="left">23</td><td align="left">88.5</td><td align="left">2.23</td></tr><tr><td align="left">&#x02003;31012</td><td align="left">extracellular matrix</td><td align="left">23</td><td align="left">88.5</td><td align="left">2.23</td></tr><tr><td align="left">&#x02003;5840</td><td align="left">ribosome</td><td align="left">15</td><td align="left">93.8</td><td align="left">2.20</td></tr><tr><td align="left">&#x02003;5842</td><td align="left">cytosolic large ribosomal subunit (sensu Eukaryota)</td><td align="left">10</td><td align="left">100</td><td align="left">2.16</td></tr><tr><td align="left">&#x02003;15934</td><td align="left">large ribosomal subunit</td><td align="left">10</td><td align="left">100</td><td align="left">2.16</td></tr><tr><td align="left">&#x02003;44420</td><td align="left">extracellular matrix part</td><td align="left">9</td><td align="left">100</td><td align="left">2.05</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>List of genes involved in the signal pathways</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td></td><td></td><td></td><td align="center" colspan="2"><bold>Fold change</bold></td></tr><tr><td></td><td></td><td></td><td></td><td colspan="2"><hr></hr></td></tr><tr><td align="center"><bold>Gene symbol</bold></td><td align="center"><bold>ProbeName</bold></td><td align="center"><bold>GenBank</bold></td><td align="center"><bold>Description</bold></td><td align="center"><bold>Overexpression</bold></td><td align="center"><bold>Knockdown</bold></td></tr></thead><tbody><tr><td align="left" colspan="6"><bold>Regulation of kinase activity</bold></td></tr><tr><td align="left">&#x02003;RB1</td><td align="left">A_23_P204850</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_000321">NM_000321</ext-link></td><td align="left">Retinoblastoma 1 (including osteosarcoma)</td><td align="center">0.74</td><td align="center">1.53</td></tr><tr><td align="left">&#x02003;GADD45B</td><td align="left">A_23_P142506</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_015675">NM_015675</ext-link></td><td align="left">Growth arrest and DNA-damage-inducible, beta</td><td align="center">1.45</td><td align="center">0.68</td></tr><tr><td align="left">&#x02003;PKIA</td><td align="left">A_23_P31765</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_006823">NM_006823</ext-link></td><td align="left">Protein kinase (cAMP-dependent, catalytic) inhibitor alpha</td><td align="center">0.68</td><td align="center">1.41</td></tr><tr><td align="left">&#x02003;TIZ/ZNF675</td><td align="left">A_24_P931755</td><td align="left"><ext-link ext-link-type="gen" xlink:href="D70835">D70835</ext-link></td><td align="left">TRAF6-inhibitory zinc finger protein</td><td align="center">0.71</td><td align="center">1.38</td></tr><tr><td align="left">&#x02003;SPRY4</td><td align="left">A_24_P269062</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_030964">NM_030964</ext-link></td><td align="left">Sprouty homolog 4 (Drosophila)</td><td align="center">2.12</td><td align="center">0.57</td></tr><tr><td align="left">&#x02003;DUSP6</td><td align="left">A_23_P139704</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_001946">NM_001946</ext-link></td><td align="left">Dual specificity phosphatase 6</td><td align="center">1.56</td><td align="center">0.74</td></tr><tr><td align="left">&#x02003;RGS4</td><td align="left">A_23_P200737</td><td align="left"><ext-link ext-link-type="gen" xlink:href="BC000737">BC000737</ext-link></td><td align="left">Regulator of G-protein signalling 4</td><td align="center">1.83</td><td align="center">0.65</td></tr><tr><td align="left">&#x02003;SPRED2</td><td align="left">A_32_P225854</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_181784">NM_181784</ext-link></td><td align="left">Sprouty-related, EVH1 domain containing 2</td><td align="center">1.52</td><td align="center">0.72</td></tr><tr><td align="left">&#x02003;NRG1</td><td align="left">A_23_P315815</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_004495">NM_004495</ext-link></td><td align="left">Neuregulin 1</td><td align="center">1.51</td><td align="center">0.74</td></tr><tr><td align="left">&#x02003;ZAK/MLTK_HUMAN</td><td align="left">A_23_P318300</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_133646">NM_133646</ext-link></td><td align="left">Sterile alpha motif and leucine zipper containing kinase AZK</td><td align="center">0.69</td><td align="center">1.56</td></tr><tr><td align="left">&#x02003;EDN1</td><td align="left">A_23_P214821</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_001955">NM_001955</ext-link></td><td align="left">Endothelin 1</td><td align="center">2.33</td><td align="center">0.49</td></tr><tr><td align="left">&#x02003;PRKD3</td><td align="left">A_24_P165656</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_005813">NM_005813</ext-link></td><td align="left">Protein kinase D3</td><td align="center">0.74</td><td align="center">1.56</td></tr><tr><td align="left">&#x02003;KITLG</td><td align="left">A_24_P133253</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_000899">NM_000899</ext-link></td><td align="left">KIT ligand</td><td align="center">0.68</td><td align="center">1.51</td></tr><tr><td align="left">&#x02003;C1QTNF6</td><td align="left">A_24_P211565</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_031910">NM_031910</ext-link></td><td align="left">C1q and tumor necrosis factor related protein 6</td><td align="center">0.47</td><td align="center">1.54</td></tr><tr><td align="left">&#x02003;C5</td><td align="left">A_23_P71855</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_001735">NM_001735</ext-link></td><td align="left">Complement component 5</td><td align="center">0.42</td><td align="center">2.62</td></tr><tr><td align="left">&#x02003;MAP4K5</td><td align="left">A_23_P205646</td><td align="left"><ext-link ext-link-type="gen" xlink:href="BC036013">BC036013</ext-link></td><td align="left">Mitogen-activated protein kinase kinase kinase kinase 5</td><td align="center">0.74</td><td align="center">1.39</td></tr><tr><td align="left">&#x02003;CCNA1</td><td align="left">A_23_P48414</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_003914">NM_003914</ext-link></td><td align="left">Cyclin A1</td><td align="center">2.51</td><td align="center">0.54</td></tr><tr><td align="left">&#x02003;CDKN2B</td><td align="left">A_24_P360674</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_078487">NM_078487</ext-link></td><td align="left">Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)</td><td align="center">1.81</td><td align="center">0.71</td></tr><tr><td align="left">&#x02003;CKS1B</td><td align="left">A_32_P175864</td><td align="left"><ext-link ext-link-type="gen" xlink:href="BG205572">BG205572</ext-link></td><td align="left">CDC28 protein kinase regulatory subunit 1B</td><td align="center">1.45</td><td align="center">0.64</td></tr><tr><td align="left">&#x02003;SERTAD1</td><td align="left">A_23_P218463</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_013376">NM_013376</ext-link></td><td align="left">SERTA domain containing 1</td><td align="center">1.51</td><td align="center">0.75</td></tr><tr><td align="left" colspan="6"><bold>Angiogenesis</bold></td></tr><tr><td align="left">&#x02003;CEACAM1</td><td align="left">A_24_P382319</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_001712">NM_001712</ext-link></td><td align="left">Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)</td><td align="center">0.60</td><td align="center">1.78</td></tr><tr><td align="left">&#x02003;COL18A1</td><td align="left">A_23_P211212</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_030582">NM_030582</ext-link></td><td align="left">Collagen, type XVIII, alpha 1</td><td align="center">0.74</td><td align="center">0.66</td></tr><tr><td align="left">&#x02003;CTGF</td><td align="left">A_23_P19663</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_001901">NM_001901</ext-link></td><td align="left">Connective tissue growth factor</td><td align="center">3.88</td><td align="center">0.24</td></tr><tr><td align="left">&#x02003;MYH9</td><td align="left">A_23_P57497</td><td align="left"><ext-link ext-link-type="gen" xlink:href="BC011915">BC011915</ext-link></td><td align="left">Myosin, heavy polypeptide 9, non-muscle</td><td align="center">1.34</td><td align="center">0.75</td></tr><tr><td align="left">&#x02003;NRP2</td><td align="left">A_24_P50801</td><td align="left"><ext-link ext-link-type="gen" xlink:href="AF280546">AF280546</ext-link></td><td align="left">Neuropilin 2</td><td align="center">1.77</td><td align="center">0.59</td></tr><tr><td align="left">&#x02003;PLXDC1</td><td align="left">A_23_P3911</td><td align="left"><ext-link ext-link-type="gen" xlink:href="BC036059">BC036059</ext-link></td><td align="left">Plexin domain containing 1</td><td align="center">0.63</td><td align="center">1.38</td></tr><tr><td align="left">&#x02003;VEGF</td><td align="left">A_23_P70398</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_003376">NM_003376</ext-link></td><td align="left">Vascular endothelial growth factor</td><td align="center">0.75</td><td align="center">1.31</td></tr><tr><td align="left">&#x02003;CXCL12</td><td align="left">A_23_P202448</td><td align="left"><ext-link ext-link-type="gen" xlink:href="U19495">U19495</ext-link></td><td align="left">Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1)</td><td align="center">0.73</td><td align="center">1.37</td></tr><tr><td align="left">&#x02003;CYR61</td><td align="left">A_23_P46426</td><td align="left"><ext-link ext-link-type="gen" xlink:href="Z97068">Z97068</ext-link></td><td align="left">Cysteine-rich, angiogenic inducer, 61</td><td align="center">1.74</td><td align="center">0.44</td></tr><tr><td align="left">&#x02003;EDN1</td><td align="left">A_23_P214821</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_001955">NM_001955</ext-link></td><td align="left">Endothelin 1</td><td align="center">2.33</td><td align="center">0.49</td></tr><tr><td align="left">&#x02003;SEMA5A</td><td align="left">A_23_P213415</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_003966">NM_003966</ext-link></td><td align="left">Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and sh</td><td align="center">0.28</td><td align="center">2.26</td></tr><tr><td align="left">&#x02003;IL17F</td><td align="left">A_23_P167882</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_052872">NM_052872</ext-link></td><td align="left">Interleukin 17F</td><td align="center">1.78</td><td align="center">2.01</td></tr><tr><td align="left">&#x02003;RUNX1</td><td align="left">A_24_P34155</td><td align="left"><ext-link ext-link-type="gen" xlink:href="X90980">X90980</ext-link></td><td align="left">Runt-related transcription factor 1 (acute myeloid leukemia 1; aml1 oncogene)</td><td align="center">1.48</td><td align="center">0.74</td></tr><tr><td align="left">&#x02003;THBS1</td><td align="left">A_23_P206212</td><td align="left"><ext-link ext-link-type="gen" xlink:href="X04665">X04665</ext-link></td><td align="left">Thrombospondin 1</td><td align="center">1.97</td><td align="center">0.59</td></tr><tr><td align="left" colspan="6"><bold>Brain development</bold></td></tr><tr><td align="left">&#x02003;APAF1</td><td align="left">A_23_P36611</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_181861">NM_181861</ext-link></td><td align="left">Apoptotic protease activating factor</td><td align="center">0.58</td><td align="center">1.36</td></tr><tr><td align="left">&#x02003;ATM</td><td align="left">A_23_P35916</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_000051">NM_000051</ext-link></td><td align="left">Ataxia telangiectasia mutated (includes complementation groups A, C and D)</td><td align="center">0.63</td><td align="center">1.35</td></tr><tr><td align="left">&#x02003;CXCL12</td><td align="left">A_23_P202448</td><td align="left"><ext-link ext-link-type="gen" xlink:href="U19495">U19495</ext-link></td><td align="left">Chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1)</td><td align="center">0.73</td><td align="center">1.37</td></tr><tr><td align="left">&#x02003;SEPP1</td><td align="left">A_23_P121926</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_005410">NM_005410</ext-link></td><td align="left">Selenoprotein P, plasma, 1</td><td align="center">0.66</td><td align="center">1.36</td></tr><tr><td align="left">&#x02003;SMARCA1</td><td align="left">A_23_P44244</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_003069">NM_003069</ext-link></td><td align="left">SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1</td><td align="center">0.43</td><td align="center">1.40</td></tr><tr><td align="left">&#x02003;ATRX</td><td align="left">A_24_P348660</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_000489">NM_000489</ext-link></td><td align="left">Alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae)</td><td align="center">0.60</td><td align="center">1.49</td></tr><tr><td align="left">&#x02003;NOTCH3</td><td align="left"><ext-link ext-link-type="gen" xlink:href="A_32_P42895">A_32_P42895</ext-link></td><td align="left">A_32_P42895</td><td align="left">Notch homolog 3 (Drosophila)</td><td align="center">0.68</td><td align="center">1.46</td></tr><tr><td align="left">&#x02003;PRKG1</td><td align="left">A_23_P136041</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_006258">NM_006258</ext-link></td><td align="left">Protein kinase, cGMP-dependent, type I</td><td align="center">0.43</td><td align="center">1.34</td></tr><tr><td align="left">&#x02003;ATP7A</td><td align="left">A_23_P217737</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_000052">NM_000052</ext-link></td><td align="left">ATPase, Cu++ transporting, alpha polypeptide (Menkes syndrome)</td><td align="center">0.48</td><td align="center">1.52</td></tr><tr><td align="left">&#x02003;FOXP2</td><td align="left">A_24_P16559</td><td align="left"><ext-link ext-link-type="gen" xlink:href="AF467257">AF467257</ext-link></td><td align="left">forkhead box P2</td><td align="center">0.67</td><td align="center">1.40</td></tr><tr><td align="left">&#x02003;CEP290</td><td align="left">A_23_P36865</td><td align="left"><ext-link ext-link-type="gen" xlink:href="AB002371">AB002371</ext-link></td><td align="left">Centrosome protein cep290</td><td align="center">0.70</td><td align="center">1.43</td></tr><tr><td align="left" colspan="6"><bold>Response to DNA damage stimulus</bold></td></tr><tr><td align="left">&#x02003;ZAK/NP_598407.1</td><td align="left">A_23_P318300</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_133646">NM_133646</ext-link></td><td align="left">Sterile alpha motif and leucine zipper containing kinase AZK</td><td align="center">0.69</td><td align="center">1.56</td></tr><tr><td align="left">&#x02003;BRCA1</td><td align="left">A_23_P207400</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_007294">NM_007294</ext-link></td><td align="left">Breast cancer 1, early onset</td><td align="center">0.71</td><td align="center">1.3</td></tr><tr><td align="left">&#x02003;ATM</td><td align="left">A_23_P35916</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_000051">NM_000051</ext-link></td><td align="left">Ataxia telangiectasia mutated (includes complementation groups A, C and D)</td><td align="center">0.63</td><td align="center">1.35</td></tr><tr><td align="left">&#x02003;ATRX</td><td align="left">A_24_P348660</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_000489">NM_000489</ext-link></td><td align="left">Alpha thalassemia/mental retardation syndrome X-linked (RAD54 homolog, S. cerevisiae)</td><td align="center">0.60</td><td align="center">1.49</td></tr><tr><td align="left">&#x02003;BRCA2</td><td align="left">A_23_P99452</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_000059">NM_000059</ext-link></td><td align="left">Breast cancer 2, early onset</td><td align="center">0.62</td><td align="center">1.3</td></tr><tr><td align="left">&#x02003;BTG2</td><td align="left">A_23_P62901</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_006763">NM_006763</ext-link></td><td align="left">BTG family, member 2</td><td align="center">0.72</td><td align="center">1.35</td></tr><tr><td align="left">&#x02003;Q6P2G2_HUMAN</td><td align="left">A_24_P361457</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_173627">NM_173627</ext-link></td><td align="left">Hypothetical protein FLJ35220 (FLJ35220)</td><td align="center">0.63</td><td align="center">1.49</td></tr><tr><td align="left">&#x02003;RBM14</td><td align="left">A_23_P161644</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_032886">NM_032886</ext-link></td><td align="left">RNA-binding motif protein 14</td><td align="center">0.62</td><td align="center">1.47</td></tr><tr><td align="left">&#x02003;MLH3</td><td align="left">A_24_P61520</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_014381">NM_014381</ext-link></td><td align="left">MutL homolog 3 (E. coli)</td><td align="center">0.59</td><td align="center">1.45</td></tr><tr><td align="left">&#x02003;N4BP2_HUMAN</td><td align="left">A_24_P222114</td><td align="left"><ext-link ext-link-type="gen" xlink:href="AK001542">AK001542</ext-link></td><td align="left">Nedd4 binding protein 2</td><td align="center">0.52</td><td align="center">1.47</td></tr><tr><td align="left">&#x02003;PMS1</td><td align="left">A_23_P40059</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_000534">NM_000534</ext-link></td><td align="left">PMS1 postmeiotic segregation increased 1 (S. cerevisiae)</td><td align="center">0.65</td><td align="center">1.34</td></tr></tbody></table></table-wrap><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Gene list involved in the regulation of kinase activity pathway generated by GenMAPP</bold>. The color on the left side of gene box illustrates the gene changes by <italic>ZNF191 </italic>overexpression; the color on the right indicates the gene changes by siRNA-mediated knockdown of <italic>ZNF191</italic>. Red and green indicates up-regulated and down-regulated in <italic>ZNF191 </italic>overexpression experiment, respectively. Yellow and blue indicates up-regulated and down-regulated in siRNA experiment, respectively. Grey indicates that selection criteria were not met but the gene was represented in the array. White boxes indicate that the gene was not present in the chip.</p></caption><graphic xlink:href="1471-2164-10-241-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Gene list involved in the angiogenesis pathway generated by GenMAPP</bold>. The color on the left side of gene box illustrates the gene changes by <italic>ZNF191 </italic>overexpression; the color on the right indicates the gene changes by siRNA-mediated knockdown of <italic>ZNF191</italic>. Red and green indicates up-regulated and down-regulated in <italic>ZNF191 </italic>overexpression experiment, respectively. Yellow and blue indicates up-regulated and down-regulated in siRNA experiment, respectively. Grey indicates that selection criteria were not met but the gene was represented in the array. White boxes indicate that the gene was not present in the chip.</p></caption><graphic xlink:href="1471-2164-10-241-4"/></fig><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Gene list involved in the response to DNA damage stimulus pathway generated by GenMAPP</bold>. The color on the left side of gene box illustrates the gene changes by <italic>ZNF191 </italic>overexpression; the color on the right indicates the gene changes by siRNA-mediated knockdown of <italic>ZNF191</italic>. Red and green indicates up-regulated and down-regulated in <italic>ZNF191 </italic>overexpression experiment, respectively. Yellow and blue indicates up-regulated and down-regulated in siRNA experiment, respectively. Grey indicates that selection criteria were not met but the gene was represented in the array. White boxes indicate that the gene was not present in the chip.</p></caption><graphic xlink:href="1471-2164-10-241-5"/></fig><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>Gene list involved in the brain development pathway generated by GenMAPP</bold>. The color on the left side of gene box illustrates the gene changes by <italic>ZNF191 </italic>overexpression; the color on the right indicates the gene changes by siRNA-mediated knockdown of <italic>ZNF191</italic>. Red and green indicates up-regulated and down-regulated in <italic>ZNF191 </italic>overexpression experiment, respectively. Yellow and blue indicates up-regulated and down-regulated in siRNA experiment, respectively. Grey indicates that selection criteria were not met but the gene was represented in the array. White boxes indicate that the gene was not present in the chip.</p></caption><graphic xlink:href="1471-2164-10-241-6"/></fig></sec><sec><title>Quantitative Real-Time RT-PCR</title><p>Twenty-one interested genes were selected and subjected to real-time PCR analysis to confirm our microarrays results. As shown in Figure <xref ref-type="fig" rid="F7">7</xref>, the direction of regulation of <italic>ATP7A, RECK, PDGFRB, BMPR2, RB1, BRCA1, BRCA2, ATM, ATRX, IFI16, CCNB2, MYO6, GADD45B, SEMA5A, NRP2, CTGF, C5, VEGF, THBS1, KITLG and FOXP2 </italic>(expect for <italic>CCNB2</italic>) by the overexpression and knockdown of ZNF191 was consistent with the microarray results.</p><fig position="float" id="F7"><label>Figure 7</label><caption><p><bold>Quantitative real-time PCR confirmation of the microarray results</bold>. qPCR was performed on 21 genes that showed differential regulation in response to <italic>ZNF191 </italic>overexpression and knockdown by siRNA. Gene expression levels are shown as the mean normalized to the expression of the housekeeping gene <italic>GAPDH</italic>. Each sample was measured in triplicate. <italic>Columns</italic>, mean of three independent experiments; <italic>bars</italic>, SD. Comparison of fold change produced by microarray with relative expression ratio obtained from real-time PCR, with good concordance.</p></caption><graphic xlink:href="1471-2164-10-241-7"/></fig></sec></sec><sec><title>Discussion</title><p>In this study, we identify genes modified by the ZNF191 transcription factor with a combined strategy of transient overexpression and transient knockdown (KD) in a cellular model (HEK293), using oligonucleotide microarray technology. Several gene pathways were revealed by MAPPfinder to be involved in processes of the regulation of kinase activity, transcription, angiogenesis, brain development and response to DNA damage.</p><p>Pathway of regulation of kinase activity was significantly affected (Z-score 2.73). This pathway had a large number of expression changes, mostly due to the regulation of 12 genes (<italic>GADD45B, SPRY4, DUSP6, RGS4, SPRED2, NRG1, EDN1, CCNA1, CDKN2B, CKS1B, SERTAD1 </italic>and <italic>DUSP6</italic>), which were up-regulated in the <italic>ZNF191</italic>-overexpressed cells and down-regulated in the <italic>ZNF191 </italic>knockdown cells. In additional, 8 genes (<italic>KITLG, PKIA, RB1, ZAK, PRKD3, C1QTNF6, C5 </italic>and <italic>MAP4K5</italic>) were down-regulated in the <italic>ZNF191</italic>-overexpressed cells and up-regulated in the <italic>ZNF191 </italic>knockdown cells. A map of the genes involved in regulation of kinase activity was shown in Figure <xref ref-type="fig" rid="F3">3</xref>. <italic>GADD45B</italic>, originally termed <italic>MyD118</italic>, is first cloned as a myeloid differentiation primary response gene. It can be induced in the absence of protein synthesis following treatment of M1 myeloblastic leukemia cells with differentiation inducers[<xref ref-type="bibr" rid="B34">34</xref>], suggesting that GADD45B play a role in hematopoiesis. KITLG is a pleiotropic factor that acts in utero in germ cell and neural cell development, and hematopoiesis[<xref ref-type="bibr" rid="B35">35</xref>]. Accordingly, <italic>ZNF191 </italic>has been isolated from bone marrow and promyelocytic leukemia cell lines [<xref ref-type="bibr" rid="B26">26</xref>]. These data infer that ZNF191 may play a role in hematopoiesis.</p><p>Angiogenesis was another pathway markedly affected by ZNF191 (Z-score 2.31). As shown in Figure <xref ref-type="fig" rid="F4">4</xref>, <italic>CTGF, CYR61, EDN1, MYH9, NRP2, RUNX1, THBS1 </italic>were up-regulated in the <italic>ZNF191</italic>-overexpressed cells, and down-regulated in the knockdown cells. In addition, <italic>CEACAM1, PLXDC1, CXCL12, SEMA5A </italic>and <italic>VEGF </italic>were down-regulated in the <italic>ZNF191</italic>-overexpressed cells, and up-regulated in the knockdown cells. Angiogenesis, the growth of new blood vessels, is required for a variety of normal proliferative processes. Furthermore, angiogenesis is well established as also playing an important role in neoplastic growth and metastasis. VEGF is a potent stimulator of angiogenesis. <italic>ZNF191 </italic>has been reported to be up-regulated in angiogenic tumor nodules where <italic>VEGF </italic>expression is significantly decreased compared with preangiogenic nodules[<xref ref-type="bibr" rid="B36">36</xref>]. In this study, our result in HEK293 cells is consistent with the findings that in human breast carcinoma cells overexpression of <italic>ZNF191 </italic>results in a significant down-regulation of <italic>VEGF</italic>, whereas silencing of <italic>ZNF191 </italic>with small interfering RNA leads to increased <italic>VEGF </italic>expression as well as the same inverse correlation between <italic>ZNF191 </italic>and <italic>VEGF </italic>observed in malignant tissues from human colon and breast biopsies [<xref ref-type="bibr" rid="B36">36</xref>]. In addition, thrombospondin-1 (THBS1/TSP-1) has been shown to inhibit angiogenesis through direct effects on endothelial cell migration and survival, and through effects on vascular endothelial cell growth factor bioavailability. Aside from the inhibitory activity of angiogenesis, THBS1 also suppresses tumor growth by activating transforming growth factor beta and affects tumor cell function through interaction with cell surface receptors and regulation of extracellular proteases[<xref ref-type="bibr" rid="B37">37</xref>]. The data in this study revealed that overexpression of <italic>ZNF191 </italic>resulted in a significant up-regulation of <italic>THBS1</italic>, whereas silencing of ZNF191 led to decreased <italic>THBS1 </italic>expression in HEK293 cells. Taken together, these data suggest that ZNF191 may participate in negative regulation of angiogenesis. Furthermore, BMPR2 is overexpressed in the majority of human lung carcinomas independent of cell type[<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref>]. PDGFR expression in colorectal cancer significantly correlates with lymphatic dissemination[<xref ref-type="bibr" rid="B40">40</xref>]. MYO6 (myosin VI) is critical in maintaining the malignant properties of the majority of human prostate cancers diagnosed today[<xref ref-type="bibr" rid="B41">41</xref>]. The finding that overexpression of <italic>ZNF191 </italic>significantly down-regulated <italic>BMPR2, PDGFR </italic>and <italic>MYO6</italic>, whereas silencing of ZNF191 increased <italic>BMPR2, PDGFR </italic>and <italic>MYO6 </italic>expression suggests a tumor suppressor role for ZNF191 in human cancers.</p><p>The response to DNA damage node was significantly affected (Z-score 2.4), mostly due to the regulation of <italic>BRCA1, BRCA2, ATM, BTG2 </italic>and <italic>ATRX </italic>(Figure <xref ref-type="fig" rid="F5">5</xref>). The most obvious explanation for this induction was that it was related to initiation of DNA replication. Indeed, DNA repair function is complementary to DNA replication, as the latter process is not error-free and produces mismatches that need to be repaired. However, we reported here that overexpression or elimination of <italic>ZNF191 </italic>affected the upstream regulators of the DNA damage pathway, such as ATM, ATRX, BRCA2 and BTG2. These data suggest that ZNF191 may be involved in the control of DNA damage response in addition to the regulation of DNA replication and concurrent DNA repair. Microarray and real-time PCR showed that RB1, ATM, ATRX and BRCA1 genes were down-regulated in the <italic>ZNF191</italic>-overexpressed cells (Figure <xref ref-type="fig" rid="F7">7</xref>). Accordingly, RB1 knockdown by siRNA caused the down-regulation of ATM, ATRX and BRCA1[<xref ref-type="bibr" rid="B42">42</xref>]. <italic>RB1 </italic>mRNA level was down-regulated in MCF-7 breast carcinoma cells by the overexpression of <italic>ZNF191 </italic>(data not published).</p><p>Mice <italic>Zfp191 </italic>transcript is detected early during embryogenesis in ectodermal, endodermal, mesodermal and extra-embryonic tissues. It is particularly observed in the developing central nervous system (CNS)[<xref ref-type="bibr" rid="B43">43</xref>]. In rat, <italic>ZNF191 </italic>mRNA is present at high levels in total embryonic head, and abundant in catecholaminergic tissues including substantia nigra, hypothalamus and olfactory bulb as well as peripheral catecholaminergic tissue adrenal medulla[<xref ref-type="bibr" rid="B27">27</xref>]. In human, <italic>ZNF191 </italic>transcript is also detected in brain[<xref ref-type="bibr" rid="B27">27</xref>]. These studies demonstrate an important role of ZNF191 in brain development. Interestingly, in support with previous studies, our results showed a node affected by <italic>ZNF191 </italic>was the brain development node (Z-score 2.27). 11 genes (<italic>ATP7A, FOXP2, APAF1, ATM, CXCL12, SEPP1, SMARCA1, ATRX, NOTCH3, PRKG1</italic>, and <italic>CEP290</italic>) down-regulated in the <italic>ZNF191</italic>-overexpressed cells and up-regulated in the <italic>ZNF191 </italic>knockdown cells (Figure <xref ref-type="fig" rid="F6">6</xref>). The human copper-transporting ATP7A is essential for dietary copper uptake, normal development and function of the CNS, and regulation of copper homeostasis in the body[<xref ref-type="bibr" rid="B44">44</xref>]. In addition, studies on Alzheimer's disease (AD) suggest an important role for copper in the brain, with some AD therapies focusing on mobilising copper in AD brains[<xref ref-type="bibr" rid="B45">45</xref>]. The transport of copper into the brain is complex and involves numerous players, including amyloid precursor protein, A beta peptide and cholesterol[<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B46">46</xref>]. Interestingly, in a yeast two-hybrid experiment using the SCAN domain of ZNF191 as bait, we identified that the zinc finger transcription factor ZNF191 can interact with NAE1(NEDD8 activating enzyme E1 subunit 1; amyloid beta precursor protein binding protein 1, 59 kDa) (unpublished data). <italic>FOXP2 </italic>mutations in humans are associated with a disorder that affects both the comprehension of language and its production, speech[<xref ref-type="bibr" rid="B47">47</xref>]. <italic>ZNF191 </italic>transcript was abundant in the mesencephalon, a structure that contains the major rat embryonic catecholaminergic tissues[<xref ref-type="bibr" rid="B27">27</xref>]. Accordingly, ZNF191 can specifically interact with the widespread TCAT motif which constitutes the HUMTH01 microsatellite in the tyrosine hydroxylase (<italic>TH</italic>) gene (encoding the rate-limiting enzyme in the synthesis of catecholamines)[<xref ref-type="bibr" rid="B27">27</xref>]. Allelic variations of HUMTH01 are known to have a quantitative silencing effect on <italic>TH </italic>gene expression and to correlate with quantitative and qualitative changes in the binding by ZNF191[<xref ref-type="bibr" rid="B27">27</xref>]. In this study, overexpression of <italic>ZNF191 </italic>resulted in a significant down-regulation of <italic>TH</italic>, whereas knockdown of <italic>ZNF191 </italic>resulted in a non-significant change of <italic>TH </italic>level. The expression level of the TH gene is indistinguishable between the wild-type, <italic>Zfp191</italic><sup>+/-</sup>, and <italic>Zfp191</italic><sup>-/- </sup>mice[<xref ref-type="bibr" rid="B32">32</xref>]. These data suggest that other genes may compensate at least in part for the loss of ZNF191 activity, ameliorating the effect of the <italic>ZNF191 </italic>knockdown. Taken together, these data suggest that ZNF191 may be involved in the brain development and the neuropsychiatric diseases.</p><p>We have to point out that in the knockdown experiments we can only deduce the level of ZNF191 protein by the level of mRNA of ZNF191 because no antibody against the ZNF191 factor is commercially available and the turn-over of the protein is still unknown. So there is no mean to ascertain whether and when the ZNF191 protein is reduced significantly. In addition, in this study HEK293 cells were used as a cellular model to identify genes modified by the ZNF191 transcription factor. Some other cells could give at least partially over transcriptome modification. Furthermore, the transcriptional response found upon alteration of ZNF191 levels does not necessarily imply that this transcription factor regulates the differentially expressed genes. Many of the observed changes could be downstream and not direct effects of ZNF191 regulation. A proof of direct regulation would require a promoter analysis or some kind of DNA-protein binding experiment or in silico analysis.</p></sec><sec><title>Conclusion</title><p>We applied overexpression and siRNA-mediated gene silencing coupled with microarray screening and systematic pathway analysis to obtain insights into the pathways controlled by the target genes. We found that ZNF191 regulated the expression of a large group of genes involved in regulation of kinase activity, angiogenesis, brain development and response to DNA damage. Our analysis reveals that ZNF191 is a pleiotropic factor in hematopoiesis, brain development, and human cancers. Our approach can be used in functional genomics to elucidate the role of other transcription factors.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Cell culture and transfection</title><p>HEK-293 cells were cultured in DMEM medium supplemented with 10% fetal bovine serum (FBS) in an atmosphere of 95% air, 5% CO<sub>2 </sub>at 37&#x000b0;C. Cells were plated into 60 mm dishes without antibiotics 24 h prior to transfection. The recombinant plasmids, or control vector, were transfected into HEK-293 cells using Lipofectamine 2000 reagents according to the manufacturer's instructions. HEK-293 cells transfected with each cDNA or siRNA were lysed after 24 h or 48 h to isolate total RNA.</p></sec><sec><title>Plasmids</title><p>The cDNA clone of <italic>ZNF191 </italic>was provided by Prof. Long Y. (Genetics Institute, Fudan University, Shanghai, China). <italic>ZNF191 </italic>cDNA was cloned into pcDNA3 (Invitrogen) by using HindIII and XhoI restriction sites. The cloning was verified by DNA sequencing. The hairpin siRNA expression vectors against <italic>ZNF191 </italic>were previously generated [<xref ref-type="bibr" rid="B32">32</xref>].</p></sec><sec><title>RNA isolation</title><p>Total RNA was extracted using the Trizol reagent (Invitrogen) and purified on RNeasy columns (Qiagen). The amount and quality of RNA preparations were evaluated on the Agilent 2100 Bioanalyzer with RNA6000 Nano Reagents and Supplies (Agilent).</p></sec><sec><title>Microarray hybridization</title><p>Five hundred nanograms of RNA were reverse-transcribed to cDNA during which process a T7 sequences was introduced into cDNA. T7 RNA polymerase-driven RNA synthesis was used for the preparation and labeling of cRNA with Cy3 (the reference sample) and Cy5 (the treated sample), respectively. A Qiagen RNeasy Mini Kit (Qiagen Inc., Valencia, CA) was used to purify fluorescent cRNA probes. An equal amount (1 &#x003bc;g) of Cy3 and Cy5 labeled probes were mixed and used for hybridization on one Agilent 4 &#x000d7; 44 K Human Whole-Genome 60-mer oligonucleotide microarrays(Agilent Techonologies Inc., Santa Clara, CA) following the protocol provided by the manufacturer.</p></sec><sec><title>Data acquisition and processing</title><p>Microarrays were scanned with a dynamic autofocus microarray scanner (Agilent dual laser DNA microarray scanner, Agilent technologies, Palo Alto, CA, USA), using Agilent-provided parameters (Red and Green PMT were each set at 100%, and scan resolution was set to 10 &#x003bc;m). The Feature Extraction Software v7.5 (Agilent Technologies) was used to extract and analyse the signals. Agilent-provided settings were used except for subtraction of the local background and adjustment of the global background. Poor quality features that were either saturated in the two channels (50% of pixels &#x0003e; saturation threshold) or non-uniform were flagged. Only those features with a signal-to-noise ratio (SNR) of up to 2.6 in at least one channel and significantly different from the local background (two sided Student's t-test &#x0003c; 0.05) were used for further analysis. The mean signal ratio of the two fluorescent intensities (Cy-5 treated cRNA/Cy-3 reference cRNA) is expressed as a logarithm (base 2), providing a relative quantitative gene expression measurement between two samples. For subsequent analysis, we used mean-centered log2 of the normalized (linear &#x00026; lowess method) sample: reference ratio. Microarray data meeting a criterion (&#x0003e; 1.2-fold change, Flag = 0, S/N &#x0003e; 2.6 and pValueLogRatio &#x0003c; 0.05) were considered to be significant and used for further analysis.</p></sec><sec><title>Pathway analysis</title><p>The GeneMapp and MappFinder software packages <ext-link ext-link-type="uri" xlink:href="http://www.genmapp.org"/> were used for pathway analysis of the significantly altered genes identified in both transient overexpression and transient knockdown of the <italic>ZNF191</italic>gene. The MAPPFinder works with GenMAPP and uses the annotations from the Gene Ontology (GO) Consortium to identify global biological trends in gene expression data. MAPPFinder relates microarray data to each term in the GO hierarchy, calculates the percentage of genes changed within each GO term, and generates a gene expression profile at the level of biological processes, cellular components, and molecular functions that allows for identification of specific biological pathways. MAPPFinder then calculates the total number of genes changed within a "parent GO term" and all of its "children" (local MAPPs) using Fisher's exact test. The results are expressed as a "z score" for a particular pathway, and values greater than 2 were considered to be significant. GenMAPP was also used to view and analyze microarray data on biological pathways[<xref ref-type="bibr" rid="B33">33</xref>].</p></sec><sec><title>Quantitative real-time PCR</title><p>Twenty-one interested genes were selected for validation by real time PCR. cDNAs were prepared from 1 &#x003bc;g of total RNA using AMV reverse transcriptase (Promega) and random primers according to the manufacturer's protocol. For each gene, PCR reactions were run three times on one sample. PCR was performed on Chromo4 Multicolor Real-Time Detection System (Bio-Rad, Inc.) in 20 &#x003bc;l reactions by using the SYBR&#x02122; Green PCR Master Mix (TaKaRa). The reaction was repeated for 40 cycles; each cycle consisted of denaturing at 95&#x000b0;C for 15 s, annealing and synthesis at 60&#x000b0;C for 1 min as per manufacturer's instructions. The relative amounts of transcript of the tested genes were normalized by GAPDH endogenous control primers set. The average ratios of relative amounts of transcript in the <italic>ZNF191</italic>-overexpressed cells or <italic>ZNF191 </italic>knockdown cells versus empty vector cells from three replicate runs were calculated. Quantitative values are obtained from the cycle number (Ct value) using Opticon Monitor 3.1 (Bio-Rad) according to the manufacturer's instructions. The threshold cycle (C<sub>T</sub>) values were averaged from the values obtained from each reaction, and each gene was normalized to GAPDH level. Each gene of interest and GAPDH were tested in triplicates to determine the Ct-difference. These Ct values were averaged and the difference between the GAPDH Ct (Avg) and the gene of interest Ct (Avg) was calculated (Ct-diff). The fold change was calculated by the 2-&#x00394;<sup>CT</sup>, where &#x00394;&#x00394;CT = (C<sub>T</sub>-treated-C<sub>T</sub>-contrl). C<sub>T</sub>-treated means the signal of an individual gene expressed in <italic>ZNF191</italic>-overexpressed or knockdown samples, while C<sub>T</sub>-control means the signal of the same gene expressed in control samples. The relative expression of the gene of interest was analyzed using the 2-&#x00394;&#x00394;<sup>CT </sup>method [<xref ref-type="bibr" rid="B48">48</xref>]. Because SYBR Green binding is not sequence specific, careful design and validation of each primer pair, as well as cautious manipulation of RNA were undertaken to ensure that only target gene sequence-specific, non-genomic products were amplified by real-time PCR. To achieve this, primers were designed to either span or flank introns. PCR primers are listed in Additional file <xref ref-type="supplementary-material" rid="S4">4</xref>. A dissociation curve analysis was performed at the end of the amplification process in order to verify the specificity of the PCR products. The same PCR products were also evaluated by agarose gel electrophoresis. Data analysis and graphics were the results (mean &#x000b1; SEM) of three different experiments.</p></sec><sec><title>Semi-quantitative PCR</title><p>Semi-quantitative PCRs were performed with Zfp191 specific primers (forward: 5'-ATCAGCGGTGGCCACATCAA-3' and reverse: 5'-GATGGGCCCAACCCAATATAT-3'), which yielded 481 bp products. To serve as an internal control, a 381 bp fragment of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA was co-amplified with primers (forward, 5'-AACTTTGGTATCGTGGAAGGA-3'; reverse, 5'-GGAGGAGTGGGTGTCGCTGT-3'). The PCRs were carried out for 25&#x02013;40 cycles at 94&#x000b0;C for 1 min, 55&#x000b0;C for 1 min, and 72&#x000b0;C for 1 min with a final extension of 5 min at 72&#x000b0;C. All RT-PCR experiments were repeated at least twice and the products were electrophoresed on 1.5% agarose gels containing ethidium bromide.</p></sec></sec><sec><title>Authors' contributions</title><p>JL was involved in all experiments, experimental design and bioinformatics analyses. XC and YL co-drafted the manuscript, performed Real RT-PCR. XG and HF assisted in bioinformatics analyses and uploaded data to Gene Expression Omnibus. LQ and ZH co-drafted the manuscript and participated in cell culture. JZ co-drafted the manuscript, made revisions critically for important intellectual content.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p><bold>Regulated genes by ZNF191 overexpression</bold>. Table S1 consists of the regulated probes by <italic>ZNF191 </italic>overexpression, containing the assigned designations (Accession number and sequence name), the fold of changed expression and PValueLogRatio(smaller than 0.05)for these genes.</p></caption><media xlink:href="1471-2164-10-241-S1.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2</title><p><bold>Regulated genes by ZNF191 knockdown</bold>. Table S2 consists of the regulated probes by <italic>ZNF191 </italic>knockdown, containing the assigned designations (Accession number and sequence name), the fold of changed expression and PValueLogRatio(smaller than 0.05)for these genes.</p></caption><media xlink:href="1471-2164-10-241-S2.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S3"><caption><title>Additional file 3</title><p><bold>Commonly altered genes by <italic>ZNF191 </italic>overexpression and knockdown</bold>. Table S3 consists of the regulated probes by <italic>ZNF191 </italic>overexpression and knockdown, containing the assigned designations (Accession number and sequence name), the fold of changed expression and PValueLogRatio (smaller than 0.05) for these genes.</p></caption><media xlink:href="1471-2164-10-241-S3.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S4"><caption><title>Additional file 4</title><p><bold>List of primers used for RT-PCR</bold>. Abbreviations: see table <xref ref-type="table" rid="T2">2</xref>.</p></caption><media xlink:href="1471-2164-10-241-S4.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank Professor Long Yu for providing the cDNA clone of <italic>ZNF191</italic>.This work was supported in part by grants from the National Natural Science Foundation of China (No. 30871353 and 30400269).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghaleb</surname><given-names>AM</given-names></name><name><surname>Nandan</surname><given-names>MO</given-names></name><name><surname>Chanchevalap</surname><given-names>S</given-names></name><name><surname>Dalton</surname><given-names>WB</given-names></name><name><surname>Hisamuddin</surname><given-names>IM</given-names></name><name><surname>Yang</surname><given-names>VW</given-names></name></person-group><article-title>Kruppel-like factors 4 and 5: the yin and yang regulators of cellular proliferation</article-title><source>Cell Res</source><year>2005</year><volume>15</volume><fpage>92</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">15740636</pub-id><pub-id pub-id-type="doi">10.1038/sj.cr.7290271</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Venter</surname><given-names>JC</given-names></name><name><surname>Adams</surname><given-names>MD</given-names></name><name><surname>Myers</surname><given-names>EW</given-names></name><name><surname>Li</surname><given-names>PW</given-names></name><name><surname>Mural</surname><given-names>RJ</given-names></name><name><surname>Sutton</surname><given-names>GG</given-names></name><name><surname>Smith</surname><given-names>HO</given-names></name><name><surname>Yandell</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>CA</given-names></name><name><surname>Holt</surname><given-names>RA</given-names></name><etal></etal></person-group><article-title>The sequence of the human genome</article-title><source>Science</source><year>2001</year><volume>291</volume><fpage>1304</fpage><lpage>1351</lpage><pub-id pub-id-type="pmid">11181995</pub-id><pub-id pub-id-type="doi">10.1126/science.1058040</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lander</surname><given-names>ES</given-names></name><name><surname>Linton</surname><given-names>LM</given-names></name><name><surname>Birren</surname><given-names>B</given-names></name><name><surname>Nusbaum</surname><given-names>C</given-names></name><name><surname>Zody</surname><given-names>MC</given-names></name><name><surname>Baldwin</surname><given-names>J</given-names></name><name><surname>Devon</surname><given-names>K</given-names></name><name><surname>Dewar</surname><given-names>K</given-names></name><name><surname>Doyle</surname><given-names>M</given-names></name><name><surname>FitzHugh</surname><given-names>W</given-names></name><etal></etal></person-group><article-title>Initial sequencing and analysis of the human genome</article-title><source>Nature</source><year>2001</year><volume>409</volume><fpage>860</fpage><lpage>921</lpage><pub-id pub-id-type="pmid">11237011</pub-id><pub-id pub-id-type="doi">10.1038/35057062</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tupler</surname><given-names>R</given-names></name><name><surname>Perini</surname><given-names>G</given-names></name><name><surname>Green</surname><given-names>MR</given-names></name></person-group><article-title>Expressing the human genome</article-title><source>Nature</source><year>2001</year><volume>409</volume><fpage>832</fpage><lpage>833</lpage><pub-id pub-id-type="pmid">11237001</pub-id><pub-id pub-id-type="doi">10.1038/35057011</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schuh</surname><given-names>R</given-names></name><name><surname>Aicher</surname><given-names>W</given-names></name><name><surname>Gaul</surname><given-names>U</given-names></name><name><surname>Cote</surname><given-names>S</given-names></name><name><surname>Preiss</surname><given-names>A</given-names></name><name><surname>Maier</surname><given-names>D</given-names></name><name><surname>Seifert</surname><given-names>E</given-names></name><name><surname>Nauber</surname><given-names>U</given-names></name><name><surname>Schroder</surname><given-names>C</given-names></name><name><surname>Kemler</surname><given-names>R</given-names></name><etal></etal></person-group><article-title>A conserved family of nuclear proteins containing structural elements of the finger protein encoded by Kruppel, a Drosophila segmentation gene</article-title><source>Cell</source><year>1986</year><volume>47</volume><fpage>1025</fpage><lpage>1032</lpage><pub-id pub-id-type="pmid">3096579</pub-id><pub-id pub-id-type="doi">10.1016/0092-8674(86)90817-2</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klug</surname><given-names>A</given-names></name><name><surname>Schwabe</surname><given-names>JW</given-names></name></person-group><article-title>Protein motifs 5. Zinc fingers</article-title><source>Faseb J</source><year>1995</year><volume>9</volume><fpage>597</fpage><lpage>604</lpage><pub-id pub-id-type="pmid">7768350</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dang</surname><given-names>DT</given-names></name><name><surname>Pevsner</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>VW</given-names></name></person-group><article-title>The biology of the mammalian Kruppel-like family of transcription factors</article-title><source>Int J Biochem Cell Biol</source><year>2000</year><volume>32</volume><fpage>1103</fpage><lpage>1121</lpage><pub-id pub-id-type="pmid">11137451</pub-id><pub-id pub-id-type="doi">10.1016/S1357-2725(00)00059-5</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bieker</surname><given-names>JJ</given-names></name></person-group><article-title>Kruppel-like factors: three fingers in many pies</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>34355</fpage><lpage>34358</lpage><pub-id pub-id-type="pmid">11443140</pub-id><pub-id pub-id-type="doi">10.1074/jbc.R100043200</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaczynski</surname><given-names>J</given-names></name><name><surname>Cook</surname><given-names>T</given-names></name><name><surname>Urrutia</surname><given-names>R</given-names></name></person-group><article-title>Sp1- and Kruppel-like transcription factors</article-title><source>Genome Biol</source><year>2003</year><volume>4</volume><fpage>206</fpage><pub-id pub-id-type="pmid">12620113</pub-id><pub-id pub-id-type="doi">10.1186/gb-2003-4-2-206</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rousseau-Merck</surname><given-names>MF</given-names></name><name><surname>Huebner</surname><given-names>K</given-names></name><name><surname>Berger</surname><given-names>R</given-names></name><name><surname>Thiesen</surname><given-names>HJ</given-names></name></person-group><article-title>Chromosomal localization of two human zinc finger protein genes, ZNF24 (KOX17) and ZNF29 (KOX26), to 18q12 and 17p13-p12, respectively</article-title><source>Genomics</source><year>1991</year><volume>9</volume><fpage>154</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">2004757</pub-id><pub-id pub-id-type="doi">10.1016/0888-7543(91)90233-5</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>AJ</given-names></name><name><surname>Khachigian</surname><given-names>LM</given-names></name><name><surname>Shows</surname><given-names>T</given-names></name><name><surname>Collins</surname><given-names>T</given-names></name></person-group><article-title>Isolation and characterization of a novel zinc-finger protein with transcription repressor activity</article-title><source>J Biol Chem</source><year>1995</year><volume>270</volume><fpage>22143</fpage><lpage>22152</lpage><pub-id pub-id-type="pmid">7673192</pub-id><pub-id pub-id-type="doi">10.1074/jbc.270.38.22143</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pengue</surname><given-names>G</given-names></name><name><surname>Calabro</surname><given-names>V</given-names></name><name><surname>Bartoli</surname><given-names>PC</given-names></name><name><surname>Pagliuca</surname><given-names>A</given-names></name><name><surname>Lania</surname><given-names>L</given-names></name></person-group><article-title>Repression of transcriptional activity at a distance by the evolutionarily conserved KRAB domain present in a subfamily of zinc finger proteins</article-title><source>Nucleic Acids Res</source><year>1994</year><volume>22</volume><fpage>2908</fpage><lpage>2914</lpage><pub-id pub-id-type="pmid">8065901</pub-id><pub-id pub-id-type="doi">10.1093/nar/22.15.2908</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bellefroid</surname><given-names>EJ</given-names></name><name><surname>Poncelet</surname><given-names>DA</given-names></name><name><surname>Lecocq</surname><given-names>PJ</given-names></name><name><surname>Revelant</surname><given-names>O</given-names></name><name><surname>Martial</surname><given-names>JA</given-names></name></person-group><article-title>The evolutionarily conserved Kruppel-associated box domain defines a subfamily of eukaryotic multifingered proteins</article-title><source>Proc Natl Acad Sci USA</source><year>1991</year><volume>88</volume><fpage>3608</fpage><lpage>3612</lpage><pub-id pub-id-type="pmid">2023909</pub-id><pub-id pub-id-type="doi">10.1073/pnas.88.9.3608</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bardwell</surname><given-names>VJ</given-names></name><name><surname>Treisman</surname><given-names>R</given-names></name></person-group><article-title>The POZ domain: a conserved protein-protein interaction motif</article-title><source>Genes Dev</source><year>1994</year><volume>8</volume><fpage>1664</fpage><lpage>1677</lpage><pub-id pub-id-type="pmid">7958847</pub-id><pub-id pub-id-type="doi">10.1101/gad.8.14.1664</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sander</surname><given-names>TL</given-names></name><name><surname>Stringer</surname><given-names>KF</given-names></name><name><surname>Maki</surname><given-names>JL</given-names></name><name><surname>Szauter</surname><given-names>P</given-names></name><name><surname>Stone</surname><given-names>JR</given-names></name><name><surname>Collins</surname><given-names>T</given-names></name></person-group><article-title>The SCAN domain defines a large family of zinc finger transcription factors</article-title><source>Gene</source><year>2003</year><volume>310</volume><fpage>29</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">12801630</pub-id><pub-id pub-id-type="doi">10.1016/S0378-1119(03)00509-2</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Edelstein</surname><given-names>LC</given-names></name><name><surname>Collins</surname><given-names>T</given-names></name></person-group><article-title>The SCAN domain family of zinc finger transcription factors</article-title><source>Gene</source><year>2005</year><volume>359</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">16139965</pub-id><pub-id pub-id-type="doi">10.1016/j.gene.2005.06.022</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deuschle</surname><given-names>U</given-names></name><name><surname>Meyer</surname><given-names>WK</given-names></name><name><surname>Thiesen</surname><given-names>HJ</given-names></name></person-group><article-title>Tetracycline-reversible silencing of eukaryotic promoters</article-title><source>Mol Cell Biol</source><year>1995</year><volume>15</volume><fpage>1907</fpage><lpage>1914</lpage><pub-id pub-id-type="pmid">7891684</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schultz</surname><given-names>DC</given-names></name><name><surname>Ayyanathan</surname><given-names>K</given-names></name><name><surname>Negorev</surname><given-names>D</given-names></name><name><surname>Maul</surname><given-names>GG</given-names></name><name><surname>Rauscher</surname><given-names>FJ</given-names><suffix>3rd</suffix></name></person-group><article-title>SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins</article-title><source>Genes Dev</source><year>2002</year><volume>16</volume><fpage>919</fpage><lpage>932</lpage><pub-id pub-id-type="pmid">11959841</pub-id><pub-id pub-id-type="doi">10.1101/gad.973302</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stone</surname><given-names>JR</given-names></name><name><surname>Maki</surname><given-names>JL</given-names></name><name><surname>Blacklow</surname><given-names>SC</given-names></name><name><surname>Collins</surname><given-names>T</given-names></name></person-group><article-title>The SCAN domain of ZNF174 is a dimer</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>5448</fpage><lpage>5452</lpage><pub-id pub-id-type="pmid">11741982</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M109815200</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Honer</surname><given-names>C</given-names></name><name><surname>Ding</surname><given-names>W</given-names></name><name><surname>Koehn</surname><given-names>J</given-names></name><name><surname>Lawrence</surname><given-names>Q</given-names></name><name><surname>Coulis</surname><given-names>CM</given-names></name><name><surname>Wang</surname><given-names>LL</given-names></name><name><surname>Ballinger</surname><given-names>D</given-names></name><name><surname>Bowen</surname><given-names>BR</given-names></name><etal></etal></person-group><article-title>The SCAN domain mediates selective oligomerization</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>17173</fpage><lpage>17179</lpage><pub-id pub-id-type="pmid">10747874</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M000119200</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sander</surname><given-names>TL</given-names></name><name><surname>Haas</surname><given-names>AL</given-names></name><name><surname>Peterson</surname><given-names>MJ</given-names></name><name><surname>Morris</surname><given-names>JF</given-names></name></person-group><article-title>Identification of a novel SCAN box-related protein that interacts with MZF1B. The leucine-rich SCAN box mediates hetero- and homoprotein associations</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>12857</fpage><lpage>12867</lpage><pub-id pub-id-type="pmid">10777584</pub-id><pub-id pub-id-type="doi">10.1074/jbc.275.17.12857</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>AJ</given-names></name><name><surname>Blacklow</surname><given-names>SC</given-names></name><name><surname>Collins</surname><given-names>T</given-names></name></person-group><article-title>The zinc finger-associated SCAN box is a conserved oligomerization domain</article-title><source>Mol Cell Biol</source><year>1999</year><volume>19</volume><fpage>8526</fpage><lpage>8535</lpage><pub-id pub-id-type="pmid">10567577</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gentry</surname><given-names>JJ</given-names></name><name><surname>Rutkoski</surname><given-names>NJ</given-names></name><name><surname>Burke</surname><given-names>TL</given-names></name><name><surname>Carter</surname><given-names>BD</given-names></name></person-group><article-title>A functional interaction between the p75 neurotrophin receptor interacting factors, TRAF6 and NRIF</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>16646</fpage><lpage>16656</lpage><pub-id pub-id-type="pmid">14960584</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M309209200</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adachi</surname><given-names>H</given-names></name><name><surname>Tsujimoto</surname><given-names>M</given-names></name></person-group><article-title>Characterization of the human gene encoding the scavenger receptor expressed by endothelial cell and its regulation by a novel transcription factor, endothelial zinc finger protein-2</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>24014</fpage><lpage>24021</lpage><pub-id pub-id-type="pmid">11978792</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M201854200</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Casademunt</surname><given-names>E</given-names></name><name><surname>Carter</surname><given-names>BD</given-names></name><name><surname>Benzel</surname><given-names>I</given-names></name><name><surname>Frade</surname><given-names>JM</given-names></name><name><surname>Dechant</surname><given-names>G</given-names></name><name><surname>Barde</surname><given-names>YA</given-names></name></person-group><article-title>The zinc finger protein NRIF interacts with the neurotrophin receptor p75(NTR) and participates in programmed cell death</article-title><source>Embo J</source><year>1999</year><volume>18</volume><fpage>6050</fpage><lpage>6061</lpage><pub-id pub-id-type="pmid">10545116</pub-id><pub-id pub-id-type="doi">10.1093/emboj/18.21.6050</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>ZG</given-names></name><name><surname>Zhang</surname><given-names>QH</given-names></name><name><surname>Ye</surname><given-names>M</given-names></name><name><surname>Kan</surname><given-names>LX</given-names></name><name><surname>Gu</surname><given-names>BW</given-names></name><name><surname>He</surname><given-names>KL</given-names></name><name><surname>Shi</surname><given-names>SL</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>G</given-names></name><name><surname>Mao</surname><given-names>M</given-names></name><etal></etal></person-group><article-title>Molecular cloning of six novel Kruppel-like zinc finger genes from hematopoietic cells and identification of a novel transregulatory domain KRNB</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>35741</fpage><lpage>35748</lpage><pub-id pub-id-type="pmid">10585455</pub-id><pub-id pub-id-type="doi">10.1074/jbc.274.50.35741</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albanese</surname><given-names>V</given-names></name><name><surname>Biguet</surname><given-names>NF</given-names></name><name><surname>Kiefer</surname><given-names>H</given-names></name><name><surname>Bayard</surname><given-names>E</given-names></name><name><surname>Mallet</surname><given-names>J</given-names></name><name><surname>Meloni</surname><given-names>R</given-names></name></person-group><article-title>Quantitative effects on gene silencing by allelic variation at a tetranucleotide microsatellite</article-title><source>Hum Mol Genet</source><year>2001</year><volume>10</volume><fpage>1785</fpage><lpage>1792</lpage><pub-id pub-id-type="pmid">11532988</pub-id><pub-id pub-id-type="doi">10.1093/hmg/10.17.1785</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prost</surname><given-names>JF</given-names></name><name><surname>Negre</surname><given-names>D</given-names></name><name><surname>Cornet-Javaux</surname><given-names>F</given-names></name><name><surname>Cortay</surname><given-names>JC</given-names></name><name><surname>Cozzone</surname><given-names>AJ</given-names></name><name><surname>Herbage</surname><given-names>D</given-names></name><name><surname>Mallein-Gerin</surname><given-names>F</given-names></name></person-group><article-title>Isolation, cloning, and expression of a new murine zinc finger encoding gene</article-title><source>Biochim Biophys Acta</source><year>1999</year><volume>1447</volume><fpage>278</fpage><lpage>283</lpage><pub-id pub-id-type="pmid">10542327</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meloni</surname><given-names>R</given-names></name><name><surname>Albanese</surname><given-names>V</given-names></name><name><surname>Ravassard</surname><given-names>P</given-names></name><name><surname>Treilhou</surname><given-names>F</given-names></name><name><surname>Mallet</surname><given-names>J</given-names></name></person-group><article-title>A tetranucleotide polymorphic microsatellite, located in the first intron of the tyrosine hydroxylase gene, acts as a transcription regulatory element in vitro</article-title><source>Hum Mol Genet</source><year>1998</year><volume>7</volume><fpage>423</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">9466999</pub-id><pub-id pub-id-type="doi">10.1093/hmg/7.3.423</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kern</surname><given-names>SE</given-names></name><name><surname>Fearon</surname><given-names>ER</given-names></name><name><surname>Tersmette</surname><given-names>KW</given-names></name><name><surname>Enterline</surname><given-names>JP</given-names></name><name><surname>Leppert</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>White</surname><given-names>R</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Hamilton</surname><given-names>SR</given-names></name></person-group><article-title>Clinical and pathological associations with allelic loss in colorectal carcinoma [corrected]</article-title><source>Jama</source><year>1989</year><volume>261</volume><fpage>3099</fpage><lpage>3103</lpage><pub-id pub-id-type="pmid">2654431</pub-id><pub-id pub-id-type="doi">10.1001/jama.261.21.3099</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Fearon</surname><given-names>ER</given-names></name><name><surname>Hamilton</surname><given-names>SR</given-names></name><name><surname>Kern</surname><given-names>SE</given-names></name><name><surname>Preisinger</surname><given-names>AC</given-names></name><name><surname>Leppert</surname><given-names>M</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>White</surname><given-names>R</given-names></name><name><surname>Smits</surname><given-names>AM</given-names></name><name><surname>Bos</surname><given-names>JL</given-names></name></person-group><article-title>Genetic alterations during colorectal-tumor development</article-title><source>N Engl J Med</source><year>1988</year><volume>319</volume><fpage>525</fpage><lpage>532</lpage><pub-id pub-id-type="pmid">2841597</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>B</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name></person-group><article-title>The zinc finger transcription factor 191 is required for early embryonic development and cell proliferation</article-title><source>Exp Cell Res</source><year>2006</year><volume>312</volume><fpage>3990</fpage><lpage>3998</lpage><pub-id pub-id-type="pmid">17064688</pub-id><pub-id pub-id-type="doi">10.1016/j.yexcr.2006.08.020</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Doniger</surname><given-names>SW</given-names></name><name><surname>Salomonis</surname><given-names>N</given-names></name><name><surname>Dahlquist</surname><given-names>KD</given-names></name><name><surname>Vranizan</surname><given-names>K</given-names></name><name><surname>Lawlor</surname><given-names>SC</given-names></name><name><surname>Conklin</surname><given-names>BR</given-names></name></person-group><article-title>MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data</article-title><source>Genome Biol</source><year>2003</year><volume>4</volume><fpage>R7</fpage><pub-id pub-id-type="pmid">12540299</pub-id><pub-id pub-id-type="doi">10.1186/gb-2003-4-1-r7</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdollahi</surname><given-names>A</given-names></name><name><surname>Lord</surname><given-names>KA</given-names></name><name><surname>Hoffman-Liebermann</surname><given-names>B</given-names></name><name><surname>Liebermann</surname><given-names>DA</given-names></name></person-group><article-title>Sequence and expression of a cDNA encoding MyD118: a novel myeloid differentiation primary response gene induced by multiple cytokines</article-title><source>Oncogene</source><year>1991</year><volume>6</volume><fpage>165</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">1899477</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wehrle-Haller</surname><given-names>B</given-names></name></person-group><article-title>The role of Kit-ligand in melanocyte development and epidermal homeostasis</article-title><source>Pigment Cell Res</source><year>2003</year><volume>16</volume><fpage>287</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">12753403</pub-id><pub-id pub-id-type="doi">10.1034/j.1600-0749.2003.00055.x</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harper</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>L</given-names></name><name><surname>Loureiro</surname><given-names>RM</given-names></name><name><surname>Wu</surname><given-names>I</given-names></name><name><surname>Fang</surname><given-names>J</given-names></name><name><surname>D'Amore</surname><given-names>PA</given-names></name><name><surname>Moses</surname><given-names>MA</given-names></name></person-group><article-title>Repression of vascular endothelial growth factor expression by the zinc finger transcription factor ZNF24</article-title><source>Cancer Res</source><year>2007</year><volume>67</volume><fpage>8736</fpage><lpage>8741</lpage><pub-id pub-id-type="pmid">17875714</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-1617</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kazerounian</surname><given-names>S</given-names></name><name><surname>Yee</surname><given-names>KO</given-names></name><name><surname>Lawler</surname><given-names>J</given-names></name></person-group><article-title>Thrombospondins in cancer</article-title><source>Cell Mol Life Sci</source><year>2008</year><volume>65</volume><fpage>700</fpage><lpage>712</lpage><pub-id pub-id-type="pmid">18193162</pub-id><pub-id pub-id-type="doi">10.1007/s00018-007-7486-z</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Langenfeld</surname><given-names>EM</given-names></name><name><surname>Bojnowski</surname><given-names>J</given-names></name><name><surname>Perone</surname><given-names>J</given-names></name><name><surname>Langenfeld</surname><given-names>J</given-names></name></person-group><article-title>Expression of bone morphogenetic proteins in human lung carcinomas</article-title><source>Ann Thorac Surg</source><year>2005</year><volume>80</volume><fpage>1028</fpage><lpage>1032</lpage><pub-id pub-id-type="pmid">16122479</pub-id><pub-id pub-id-type="doi">10.1016/j.athoracsur.2005.03.094</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Langenfeld</surname><given-names>EM</given-names></name><name><surname>Langenfeld</surname><given-names>J</given-names></name></person-group><article-title>Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors</article-title><source>Mol Cancer Res</source><year>2004</year><volume>2</volume><fpage>141</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">15037653</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wehler</surname><given-names>TC</given-names></name><name><surname>Frerichs</surname><given-names>K</given-names></name><name><surname>Graf</surname><given-names>C</given-names></name><name><surname>Drescher</surname><given-names>D</given-names></name><name><surname>Schimanski</surname><given-names>K</given-names></name><name><surname>Biesterfeld</surname><given-names>S</given-names></name><name><surname>Berger</surname><given-names>MR</given-names></name><name><surname>Kanzler</surname><given-names>S</given-names></name><name><surname>Junginger</surname><given-names>T</given-names></name><name><surname>Galle</surname><given-names>PR</given-names></name><etal></etal></person-group><article-title>PDGFRalpha/beta expression correlates with the metastatic behavior of human colorectal cancer: a possible rationale for a molecular targeting strategy</article-title><source>Oncol Rep</source><year>2008</year><volume>19</volume><fpage>697</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">18288404</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>TA</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Faith</surname><given-names>DA</given-names></name><name><surname>Hicks</surname><given-names>JL</given-names></name><name><surname>Platz</surname><given-names>EA</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Ewing</surname><given-names>CM</given-names></name><name><surname>Sauvageot</surname><given-names>J</given-names></name><name><surname>Isaacs</surname><given-names>WB</given-names></name><name><surname>De Marzo</surname><given-names>AM</given-names></name><etal></etal></person-group><article-title>A novel role of myosin VI in human prostate cancer</article-title><source>Am J Pathol</source><year>2006</year><volume>169</volume><fpage>1843</fpage><lpage>1854</lpage><pub-id pub-id-type="pmid">17071605</pub-id><pub-id pub-id-type="doi">10.2353/ajpath.2006.060316</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Semizarov</surname><given-names>D</given-names></name><name><surname>Kroeger</surname><given-names>P</given-names></name><name><surname>Fesik</surname><given-names>S</given-names></name></person-group><article-title>siRNA-mediated gene silencing: a global genome view</article-title><source>Nucleic Acids Res</source><year>2004</year><volume>32</volume><fpage>3836</fpage><lpage>3845</lpage><pub-id pub-id-type="pmid">15272085</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkh714</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khalfallah</surname><given-names>O</given-names></name><name><surname>Faucon-Biguet</surname><given-names>N</given-names></name><name><surname>Nardelli</surname><given-names>J</given-names></name><name><surname>Meloni</surname><given-names>R</given-names></name><name><surname>Mallet</surname><given-names>J</given-names></name></person-group><article-title>Expression of the transcription factor Zfp191 during embryonic development in the mouse</article-title><source>Gene Expr Patterns</source><year>2008</year><volume>8</volume><fpage>148</fpage><lpage>154</lpage><pub-id pub-id-type="pmid">18096443</pub-id><pub-id pub-id-type="doi">10.1016/j.gep.2007.11.002</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lutsenko</surname><given-names>S</given-names></name><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Burkhead</surname><given-names>JL</given-names></name><name><surname>Zuzel</surname><given-names>V</given-names></name></person-group><article-title>Cellular multitasking: the dual role of human Cu-ATPases in cofactor delivery and intracellular copper balance</article-title><source>Arch Biochem Biophys</source><year>2008</year><volume>476</volume><fpage>22</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">18534184</pub-id><pub-id pub-id-type="doi">10.1016/j.abb.2008.05.005</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Macreadie</surname><given-names>IG</given-names></name></person-group><article-title>Copper transport and Alzheimer's disease</article-title><source>Eur Biophys J</source><year>2008</year><volume>37</volume><fpage>295</fpage><lpage>300</lpage><pub-id pub-id-type="pmid">18004558</pub-id><pub-id pub-id-type="doi">10.1007/s00249-007-0235-2</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>GK</given-names></name><name><surname>Miles</surname><given-names>LA</given-names></name><name><surname>Crespi</surname><given-names>GA</given-names></name><name><surname>Morton</surname><given-names>CJ</given-names></name><name><surname>Ng</surname><given-names>HL</given-names></name><name><surname>Barnham</surname><given-names>KJ</given-names></name><name><surname>McKinstry</surname><given-names>WJ</given-names></name><name><surname>Cappai</surname><given-names>R</given-names></name><name><surname>Parker</surname><given-names>MW</given-names></name></person-group><article-title>Copper binding to the Alzheimer's disease amyloid precursor protein</article-title><source>Eur Biophys J</source><year>2008</year><volume>37</volume><fpage>269</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">18030462</pub-id><pub-id pub-id-type="doi">10.1007/s00249-007-0234-3</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scharff</surname><given-names>C</given-names></name><name><surname>Haesler</surname><given-names>S</given-names></name></person-group><article-title>An evolutionary perspective on FoxP2: strictly for the birds?</article-title><source>Curr Opin Neurobiol</source><year>2005</year><volume>15</volume><fpage>694</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">16266802</pub-id><pub-id pub-id-type="doi">10.1016/j.conb.2005.10.004</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname><given-names>KJ</given-names></name><name><surname>Schmittgen</surname><given-names>TD</given-names></name></person-group><article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method</article-title><source>Methods</source><year>2001</year><volume>25</volume><fpage>402</fpage><lpage>408</lpage><pub-id pub-id-type="pmid">11846609</pub-id><pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id></citation></ref></ref-list></back></article> 